Johnson Pharmacare Ltd Financials
Company Logo

Johnson Pharmacare Ltd Financial Statement

Johnson Pharmacare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
RevenueTBA
Operating Expense0.05
Net Profit-0.05
Net Profit MarginTBA
Earning Per ShareTBA
EBIDTA-0.05
Effective Tax RateTBA

Johnson Pharmacare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue AnnualTBA
Operating Expenses Annual0.58
Operating Profit Annual-0.58
Interest AnnualTBA
DepreciationTBA
Net Profit Annual-0.58
Tax AnnualTBA

Johnson Pharmacare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the BeginningTBA
Cash Flow from Operations-1.91
Cash Flow from Investing3.27
Cash Flow from Financing-1.35
Cash Flow at the End0.01

Johnson Pharmacare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)TBA
PBIT Margin (%)TBA
PBT Margin (%)TBA
Net PROFIT Margin (%)TBA
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)TBA
Total Debt / Equity (X)0.02
Asset Turnover Ratio (%)TBA

Johnson Pharmacare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets AnnualTBA
Total Current Assets Annual1.36
Non Current Assets Annual56.56
Total Shareholders Funds Annual56.17
Total Assets Annual57.93

Johnson Pharmacare Ltd Earning Calls

No Data Availabe

FAQS on Johnson Pharmacare Ltd Financials

As of Sep 14, 2025, Johnson Pharmacare Ltd has a market capitalization of 51.15 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Johnson Pharmacare Ltd is with a debt-to-equity ratio of 0.01.

In FY 2024 , Johnson Pharmacare Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.

Johnson Pharmacare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and -100.0% annually, respectively..

Johnson Pharmacare Ltd's current PE ratio is -88.19.

Johnson Pharmacare Ltd's ROCE averaged -1.1% from the FY ending March 2023 to 2025, with a median of -0.7%. It peaked at -0.3% in March 2024, reflecting strong capital efficiency over the period..

Johnson Pharmacare Ltd's latest EBIT is Rs. -0.58 Cr, surpassing the average EBIT of Rs. -0.69 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions